Handelsavisen
prelaunch
00
001328.SZ Shenzhen Stock Exchange Personal Products

Dencare Chongqing Oral Care Co Ltd

¥29,58
Open in Charts → Attach watcher ⌖
CNY
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
P/E
EV / Rev
Div yield
2,36 %
Op margin
12,0 %
ROE
12,0 %
Net margin
10,6 %
Debt / equity
0,00
Beta
52w range
Volume
Day range
Prev close
Open
Next earnings
Ex-dividend
TR 1Y
About

Dencare Chongqing Oral Care Co Ltd is a personal care products company that produces and sells oral care products, primarily toothpaste, in China.

Business. Dencare Chongqing Oral Care Co Ltd (001328.SZ) is a personal products company headquartered in Chongqing, China, operating within the Consumer Non-Cyclicals sector. The firm is primarily engaged in the sale of oral care products and is listed on the Shenzhen Stock Exchange. Specific details regarding its operating segments and geographic revenue mix are not disclosed in the available data.

Classification92 %
SectorConsumer Non-Cyclicals
Business sectorPersonal & Household Products & Services
IndustryPersonal Products
Generated · model-assisted
Sell-side consensus
consensus pending
— buy— hold— sell
Avg 12m price target
Upcoming events
— missing data
See all catalysts →

At a glance

Score
not yet scored
Valuation
valuation pending
Analysts
not yet wired
Ownership
not yet wired
Profitability
12,0 %
return on equity
Quality
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning 001328.
  • Sector rotation

    Sector1D1Mvs mkt
    Materials+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,6 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials−0,3 %−2,8 %−0,9 %
    Consumer Staples · THIS SECTOR−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to 001328.SZ. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    Briefing · model-assisted

    Dencare Chongqing Oral Care Co Ltd (001328.SZ) has seen its economic sector and activity classifications formally established, marking a medium-severity update to its corporate profile. The company is now categorized under the "Consumer Non-Cyclicals" economic sector, with its specific activity defined as "Personal Products." This taxonomic clarification provides a clearer framework for understanding the firm's operational focus within the broader consumer landscape. In parallel with these classification updates, the company’s risk assessment profile has been initialized with low-risk ratings for both dilution and liquidity. The dilution_risk field, previously null, is now recorded as "low," indicating a minimal threat of share value erosion from new issuances. Similarly, the liquidity_risk field has been set to "low," suggesting that the company faces limited challenges regarding the ease of trading its shares or accessing cash. These changes represent the first tracked-field updates for the company, shifting key metrics from undefined states to specific, low-severity classifications. The rationale for these assignments cites standard specification thresholds, confirming that the current operational and financial indicators do not trigger higher risk alerts. This establishes a baseline for future monitoring of the company's stability and market positioning. The significance of these updates lies in the enhanced transparency of Dencare's fundamental attributes. By defining its sector as Consumer Non-Cyclicals and its activity as Personal Products, investors can better align the company with relevant industry benchmarks. The concurrent confirmation of low dilution and liquidity risks further supports a view of structural stability, although the company currently lacks analyst coverage, index membership, or disclosed top holders to provide additional market context. [doc:001328.sz-ha-financials]

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    Dencare Chongqing Oral Care Co Ltd (001328.SZ) is a personal products company headquartered in Chongqing, China, operating within the Consumer Non-Cyclicals sector. The firm is primarily engaged in the sale of oral care products and is listed on the Shenzhen Stock Exchange. Specific details regarding its operating segments and geographic revenue mix are not disclosed in the available data.

    Classification92 %
    SectorConsumer Non-Cyclicals
    Business sectorPersonal & Household Products & Services
    IndustryPersonal Products
    AI synthesis
    GENERATED

    Dencare Chongqing Oral Care Co Ltd maintains a strong capital structure with no long-term debt and a debt-to-equity ratio of 0.0, indicating a fully equity-funded operation. The company's liquidity position is robust, with a current ratio of 3.36, suggesting it has more than three times the current assets to cover its current liabilities. Free cash flow for the period was 24.8 million CNY, while operating cash flow was 214.4 million CNY, reflecting strong cash generation from operations.

    Profitability metrics show a return on equity (ROE) of 12.03% and a return on assets (ROA) of 9.02%, both of which are strong indicators of efficient capital use and asset management. Gross profit of 893.2 million CNY and operating income of 205.5 million CNY support the company's profitability, with net income of 181.1 million CNY for the period. These figures suggest the company is performing well relative to industry norms, though specific industry medians are not provided in the data.

    The company's revenue is concentrated in a single business segment, as disclosed in its financials, with no geographic diversification data provided in the current snapshot. This lack of diversification may expose the company to regional economic or regulatory risks, though no specific geographic breakdown is available in the input data.

    Growth trajectory is not explicitly quantified in the input data, but the company's strong operating cash flow and positive free cash flow suggest it has the financial flexibility to reinvest in growth opportunities. The absence of capital expenditures in the financial snapshot implies the company may be in a maintenance or consolidation phase rather than an expansion phase.

    Risk factors are minimal, with no immediate liquidity or dilution flags detected in the risk assessment. The company has no long-term debt, and shares outstanding for both basic and diluted scenarios are identical, indicating no dilution pressure from stock options or convertible instruments. This suggests a stable capital structure with low financial risk.

    Recent events, including filings or transcripts, are not detailed in the input data, so no specific recent developments can be cited. The company's financials appear stable, with no unusual items or significant changes in operating performance reported in the available data.

    Dencare Chongqing Oral Care Co Ltd (001328.SZ) has seen its economic sector and activity classifications formally established, marking a medium-severity update to its corporate profile. The company is now categorized under the "Consumer Non-Cyclicals" economic sector, with its specific activity defined as "Personal Products." This taxonomic clarification provides a clearer framework for understanding the firm's operational focus within the broader consumer landscape. In parallel with these classification updates, the company’s risk assessment profile has been initialized with low-risk ratings for both dilution and liquidity. The dilution_risk field, previously null, is now recorded as "low," indicating a minimal threat of share value erosion from new issuances. Similarly, the liquidity_risk field has been set to "low," suggesting that the company faces limited challenges regarding the ease of trading its shares or accessing cash. These changes represent the first tracked-field updates for the company, shifting key metrics from undefined states to specific, low-severity classifications. The rationale for these assignments cites standard specification thresholds, confirming that the current operational and financial indicators do not trigger higher risk alerts. This establishes a baseline for future monitoring of the company's stability and market positioning. The significance of these updates lies in the enhanced transparency of Dencare's fundamental attributes. By defining its sector as Consumer Non-Cyclicals and its activity as Personal Products, investors can better align the company with relevant industry benchmarks. The concurrent confirmation of low dilution and liquidity risks further supports a view of structural stability, although the company currently lacks analyst coverage, index membership, or disclosed top holders to provide additional market context. [doc:001328.sz-ha-financials]

    Key takeaways
    • Dencare Chongqing Oral Care Co Ltd is a personal care products company with strong profitability and no long-term debt.
    • The company's ROE of 12.03% and ROA of 9.02% indicate efficient use of equity and assets.
    • A current ratio of 3.36 and no long-term debt suggest a strong liquidity position.
    • The company's revenue is concentrated in a single business segment, with no geographic diversification data provided.
    • No immediate liquidity or dilution risks are flagged, and the capital structure is stable.

    Bull / Bear case

    Generated · model-assisted
    — missing data

    In focus — financials by report

    Valuation

    Market price
    ¥29,58
    Market cap
    Enterprise value
    P/E
    Non-GAAP P/E
    EV / Revenue
    EV / Op income
    EV / OCF
    P / B
    P / Tangible book
    Tangible book
    ¥1.51B
    Net cash
    Current ratio
    3.4
    Debt / equity
    0.0
    ROA
    9.0%
    ROE
    12.0%
    Cash conversion
    118.0%
    CapEx / revenue
    -2.9%
    SBC / revenue
    Dilution ratio
    0.0%

    Revenue by segment

    Market share

    — missing data

    Business relationships

    — missing data

    Supply chain

    — missing data

    Peer comparison

    — missing data

    Market position

    Stress test

    — missing data

    Predictor forecast

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Consensus distribution

    sell-side coverage
    Recommendation distribution4 analysts
    Strong buy2
    Buy2
    Hold0
    Sell0
    Strong sell0
    12-month price target¥40,83 · Median ¥43,00
    Low ¥26,83High ¥52,65
    Operating income · consensus234,0M CNY
    EPS surprise
    −19,4 %
    reported vs consensus · miss
    Revenue surprise
    −15,7 %
    reported vs consensus · miss

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    Low¥26,83
    Mean¥40,83
    Median¥43,00
    High¥52,65
    Spot¥29,58
    +38.0 %implied to mean12-month sell-side price targets · ▲ spot

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskLow
    Filing-based flags
    • No immediate filing-based liquidity or dilution flags were detected.

    Benchmarks vs cohort

    Op Margin12,0 %Above median
    Net Margin10,5 %Above P75
    ROE12,0 %Above P75
    Capex / Rev-2,9 %Below median
    D/E0,00Above P75
    Cash Conv1,18Above median

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    — missing data

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    How metrics are computed
    • Dilution Ratio
      (shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
    • Capex To Revenue
      capital_expenditure / revenue
    • Return On Equity
      net_income / total_equity
    • Debt To Equity
      (short_term_debt + long_term_debt) / total_equity
    • Cash Conversion Ratio
      operating_cash_flow / net_income
    • Return On Assets
      net_income / total_assets
    Source documents
    • Dencare Chongqing Oral Care Co Ltd Market data — financials · 2026-05-26

    Ownership & reference

    Insider activity

    — missing data

    Short positioning

    — missing data

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    001328.SZCanonical
    Shenzhen Stock Exchange · CNY

    Intel & risk

    What changed

    4 tracked-field change(s) detected vs prior analysis; max severity: medium.

    • Dilution risk— → lowlow
    • Liquidity risk— → lowlow
    • Activity— → Personal Productsmedium
    • Economic sector— → Consumer Non-Cyclicalsmedium
    vs prior analysis today
    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskLow
    No immediate filing-based liquidity or dilution flags were detected.

    Evidence & claims

    From filings & derived data
    — missing data

    The Thread

    Everything we know, in order
    — missing data
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage